2m 2m 2m 2m 2m 2m 2m
- $12.4MMarket Cap
- 101.54%1-Year Change
- Shell CompaniesIndustry
Adia Nutrition (ADIA)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 74
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 06/23/2026
Company Profile
Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.
Key Executives
- Rebecca Miller
- Jenny Angeloff Singhal
- Larry Powalisz
- April
- Dawn Bell
Current Ownership Distribution
- Other94.4M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)